April 16, 2019
A national study has found that PET scans significantly influenced clinical management of patients with dementia.
March 21, 2019
Pharmaceuticals company Biogen and its partner Eisai announced that they will cease clinical trials for aducanumab after it was indicated the trials were unlikely to succeed.
August 2, 2018
The ADDF looks back at the 2018 Alzheimer's Association International Conference.
September 13, 2017
Nearly 200 academic and industry researchers came together to share updates on innovative preclinical and clinical-stage Alzheimer’s disease research at the 18th Annual Conference on Alzheimer's Drug Discovery.
July 26, 2017
A new study reveals a high percentage of former football players died with CTE, including 99% of NFL players tested.
September 27, 2016
Protein tracer shows distinctive pattern of brain protein deposition specific to this disease and typically confirmed after death
May 10, 2016
The ADDF has awarded 10 new grants to researchers developing drugs for neurodegenerative diseases and biomarkers to detect their onset and progression.
February 5, 2013
Howard Fillit, MD and George Vradenburg of USAgainstAlzheimer's issued a joint statement, responding to MEDCAC's opinion to not support Medicare reimbursement for PET amyloid imaging scans.
April 6, 2012
The FDA has approved Amyvid™, the first diagnostic test for Alzheimer's disease, for which the ADDF provided critical seed funding.